Abstract
Colonic absorption of recombinant human insulin-like growth factor I (rhIGF-I) was measured in vitro using both rat and minipig colon. The permeability coefficients were 8.03 ± 1.03 and 4.75 ± 0.43 × 10−8 cm sec−1 in the rat and minipig, respectively. The steady-state flux in rat colon was linearly related to the donor concentration over the range 1 to 10 mg/mL. rhIGF-I was metabolically stable in contact with both mucosal and serosal surfaces of washed colon for 5 hr. The amount of IGF-I permeating through the tissue was quantitated by radioimmunoassay and the identity and integrity of the permeating species were confirmed by reverse-phase HPLC, sodium dodecyl sulfate–polyacrylamide gel electrophoresis, and Western blotting. In all cases the permeant was identical to authentic rhIGF-I. The integrity of the colonic tissue in vitro was demonstrated by the maintenance of electrophysiological parameters, a secretory response to serosal theophylline, and the ability of sodium azide, a metabolic inhibitor, to abolish the barrier properties and cause a large increase in flux.
Similar content being viewed by others
REFERENCES
E. Rinderknecht and R. E. Humbel. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J. Biol. Chem. 253:2769–2776 (1978).
S. Gammeltoft. Insulin-like growth factors and insulin: Gene expression, receptors, and biological actions. In J. Martinez (ed.), Peptide Hormones as Prohormones: Processing, Biological Activity, Pharmacology, Halsted Press, New York, 1989.
V. R. Sara and K. Hall. Insulin-like growth factors and their binding proteins. Physiol. Rev. 70:591–614 (1990).
S. Hardouin, P. Hossenlopp, B. Segouia, D. Seurin, G. Portolan, C. Lassame, and M. Binoux. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. I. Circulating forms in man. Eur. J. Biochem. 170:121–132 (1987).
P. E. Walton, R. Gopinath, B. D. Burleigh, and T. D. Etherton. Administration of recombinant human insulin-like growth factor I to pigs: Determination of circulating half-lives and chromatographic profiles. Horm. Res. 31:138–142 (1989).
S. C. Hodgkinson, S. R. Davis, B. D. Burleigh, H. V. Henderson, and P. D. Gluckman. Metabolic clearance rate of insulin-like growth factor-I in fed and starved sheep. J. Endocr. 115:233–240 (1987).
D. S. Schalch, N. J. Turman, V. Marcsisin, and H. P. Guler. Short-term metabolic effects of recombinant human insulin-like growth factor I (rhIGF-I) in type II diabetes mellitus. 2nd International IGF Symposium on Insulin-Like Growth Factors/Somatomedins, 1991.
A. Giacca, R. Gupta, S. Efendic, K. Hall, A. Skottner, L. Lickley, and M. Vranic. Differential effects of IGF-I and insulin on glucoregulation and fat metabolism in depancreatized dogs. Diabetes 39:340–347 (1990).
F. M. Tomas, S. E. Knowles, P. C. Owens, L. C. Read, C. S. Chandler, S. E. Gargosky, and F. J. Ballard. Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF-I) and des(1–3)IGF-I. Biochem. J. 276:547–554 (1992).
E. M. Spencer, C. C. Liu, E. C. C. Si, and G. A. Howard, In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone 12:21–26 (1991).
S. A. W. Gibson, C. McFarlan, S. Hay, and G. T. MacFarlane. Significance of microflora in proteolysis in the colon. Appl. Env. Microbiol. 55:679–683 (1989).
M. Proano, M. Camilleri, S. F. Phillips, M. L. Brown, and G. M. Thomforde. Transit of solids through the human colon: Regional quantification in the unprepared bowel. Am. J. Physiol. 258:G856–G862 (1990).
B. Krevsky, L. S. Malmud, F. D'Ercole, A. H. Maurer, and R. S. Fisher. Colonic transit scintigraphy. A physiological approach to the quantitative measurement of colonic transit in humans. Gastroenterology 91:1102–1112 (1986).
V. S. Chadwick, S. F. Phillips, and A. F. Hofmann. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 73:247–251 (1977).
M. L. G. Gardner. Gastrointestinal absorption of intact proteins. Annu. Rev. Nutr. 8:329–350 (1988).
A. L. Warshaw, C. A. Bellini, and W. A. Walker. The intestinal mucosal barrier to intact antigenic protein. Difference between colon and small intestine. Am. J. Surg. 133:55–58 (1977).
J. Hastewell, S. Lynch, I. Williamson, R. Fox, and M. Mackay. Absorption of human calcitonin across the rat colon in vivo. Clin. Sci. 82:589–594 (1992).
A. N. Elias, I. Gordon, N. D. Vaziri, G. Chune, M. R. Pandian, G. Gwinup, and R. Wesley. Effective portal insulin delivery with enzyme-protected capsules in pancreatectomized pigs. Gen. Pharmac. 23:55–59 (1992).
E. Quadros, J. Cassidy, K. Gniecko, and S. LeRoy. Buccal and colonic absorption of CGS 16617, a novel ACE inhibitor. J. Control. Release 19:77–86 (1991).
G. Parsons and C. R. Paterson. Fluid and solute transport across rat colonic mucosa. Q. J. Exp. Physiol. 50:220–231 (1965).
R. J. Schilling and A. K. Mitra. Intestinal transports of insulin. Int. J. Pharm. 62:53–64 (1990).
B. Matuszewska, G. G. Liversidge, F. Ryan, J. Dent, and P. L. Smith. In vitro study of intestinal absorption and metabolism of 8-L-arginine vasopressin and its analogues. Int. J. Pharm. 46:111–120 (1988).
N. M. Landzert, K. Gniecko, and E. Quadros. Protein digestion in the gastrointestinal tract. Pharm. Res. 9:S179 (1992).
M. Laburthe, C. Rouyer-Fessard, and S. Gammeltoft. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am. J. Physiol. 254:G457–G462 (1988).
B. Termanini, R. V. Nardi, T. M. Finan, I. Parikh, and L. Y. Korman. Insulin-like growth factor I receptors in rabbit gastrointestinal tract. Gastroenterology 99:51–60 (1990).
J. A. McRoberts, R. Aranda, N. Riley, and H. Kang. Insulin regulates the paracellular permeability of cultured intestinal epithelial cell monolayers. J. Clin. Invest. 85:1127–1134 (1990).
J. A. McRoberts, N. Riley, R. Aranda, and H. Kang. Regulation of colonic epithelial cell tight junction permeability by insulin-like growth factors. 2nd International Symposium on Insulin-like Growth Factors/Somatomedins, 1991.
M. Narawane and V. H. L. Lee. Growth factors as penetration enhancers for transepithelial protein transport. Pharm. Res. 9:S-242 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quadros, E., Landzert, N.M., LeRoy, S. et al. Colonic Absorption of Insulin-like Growth Factor I in Vitro . Pharm Res 11, 226–230 (1994). https://doi.org/10.1023/A:1018999106684
Issue Date:
DOI: https://doi.org/10.1023/A:1018999106684